For instance, modern heart failure management with drugs like ACE inhibitors, beta-blockers, or SGLT2 inhibitors may already reduce oxidative stress indirectly by improving hemodynamics or metabolism [29,47,48]. The gene discussed is SLC5A2; the disease is heart failure.